Jørn Arnt

4.8k total citations
84 papers, 4.1k citations indexed

About

Jørn Arnt is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Jørn Arnt has authored 84 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Cellular and Molecular Neuroscience, 53 papers in Molecular Biology and 16 papers in Psychiatry and Mental health. Recurrent topics in Jørn Arnt's work include Neurotransmitter Receptor Influence on Behavior (53 papers), Neuroscience and Neuropharmacology Research (45 papers) and Receptor Mechanisms and Signaling (41 papers). Jørn Arnt is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (53 papers), Neuroscience and Neuropharmacology Research (45 papers) and Receptor Mechanisms and Signaling (41 papers). Jørn Arnt collaborates with scholars based in Denmark, United States and United Kingdom. Jørn Arnt's co-authors include John Hyttel, Jørgen Scheel‐Krüger, Connie Sánchez, Jens Perregaard, Eddi Meier, Jens‐Jørgen Larsen, Ejner K. Moltzen, Michael Didriksen, Torben Skarsfeldt and Arne Mørk and has published in prestigious journals such as Brain Research, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Jørn Arnt

84 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jørn Arnt Denmark	35	2.9k	1.7k	886	570	470	84	4.1k
Tyra Zetterström United Kingdom	31	3.5k 1.2×	1.6k 0.9×	520 0.6×	462 0.8×	585 1.2×	69	4.8k
Jean‐Michel Rivet France	41	3.6k 1.2×	2.1k 1.2×	667 0.8×	694 1.2×	696 1.5×	88	5.0k
G. L. Gessa Italy	38	3.3k 1.1×	1.6k 0.9×	755 0.9×	646 1.1×	674 1.4×	99	5.0k
Jerzy Vetulani Poland	31	2.2k 0.7×	1.4k 0.8×	538 0.6×	757 1.3×	309 0.7×	106	3.7k
Valérie Audinot France	37	2.5k 0.8×	2.1k 1.2×	417 0.5×	359 0.6×	382 0.8×	98	4.7k
Kjell Svensson United States	35	2.6k 0.9×	2.0k 1.1×	496 0.6×	223 0.4×	443 0.9×	134	4.2k
Anne Dekeyne France	33	2.1k 0.7×	1.3k 0.8×	402 0.5×	458 0.8×	502 1.1×	73	3.2k
H.C. Fibiger Canada	32	3.1k 1.0×	1.8k 1.0×	544 0.6×	628 1.1×	1.1k 2.4×	54	4.5k
Jørgen Scheel‐Krüger Denmark	40	3.4k 1.2×	1.4k 0.8×	541 0.6×	428 0.8×	1.1k 2.3×	92	5.1k
Louis A. Chiodo United States	31	2.9k 1.0×	1.6k 0.9×	700 0.8×	322 0.6×	768 1.6×	69	4.1k

Countries citing papers authored by Jørn Arnt

Since Specialization

Citations

This map shows the geographic impact of Jørn Arnt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jørn Arnt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jørn Arnt more than expected).

Fields of papers citing papers by Jørn Arnt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jørn Arnt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jørn Arnt. The network helps show where Jørn Arnt may publish in the future.

Co-authorship network of co-authors of Jørn Arnt

This figure shows the co-authorship network connecting the top 25 collaborators of Jørn Arnt. A scholar is included among the top collaborators of Jørn Arnt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jørn Arnt. Jørn Arnt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mombereau, Cédric, et al.. (2020). Brexpiprazole blocks post-traumatic stress disorder-like memory while promoting normal fear memory. Molecular Psychiatry. 26(7). 3018–3033. 15 indexed citations

Munkhof, Hanna E. van den, Jørn Arnt, Pau Celada, & Francesc Artigas. (2017). The antipsychotic drug brexpiprazole reverses phencyclidine-induced disruptions of thalamocortical networks. European Neuropsychopharmacology. 27(12). 1248–1257. 5 indexed citations

Cohen, Hagit, Joseph Zohar, Zeev Kaplan, & Jørn Arnt. (2017). Adjunctive treatment with brexpiprazole and escitalopram reduces behavioral stress responses and increase hypothalamic NPY immunoreactivity in a rat model of PTSD-like symptoms. European Neuropsychopharmacology. 28(1). 63–74. 31 indexed citations

Abrial, Erika, et al.. (2017). Asenapine modulates mood‐related behaviors and 5‐HT_1A/7receptors‐mediated neurotransmission. CNS Neuroscience & Therapeutics. 23(6). 518–525. 9 indexed citations

Clemente, Angelo Di, Carlotta Franchi, Alessandro Orrù, Jørn Arnt, & Luigi Cervo. (2011). Bifeprunox: a partial agonist at dopamine D₂ and serotonin_1A receptors, influences nicotine‐seeking behaviour in response to drug‐associated stimuli in rats. Addiction Biology. 17(2). 274–286. 11 indexed citations

Iasevoli, Felice, Carmine Tomasetti, Federica Marmo, et al.. (2010). Divergent acute and chronic modulation of glutamatergic postsynaptic density genes expression by the antipsychotics haloperidol and sertindole. Psychopharmacology. 212(3). 329–344. 46 indexed citations

Carli, Mirjana, et al.. (2010). Sertindole restores attentional performance and suppresses glutamate release induced by the NMDA receptor antagonist CPP. Psychopharmacology. 214(3). 625–637. 18 indexed citations

Etiévant, Adeline, Cécile Betry, Jørn Arnt, & Nasser Haddjeri. (2009). Bifeprunox and aripiprazole suppress in vivo VTA dopaminergic neuronal activity via D2 and not D3 dopamine autoreceptor activation. Neuroscience Letters. 460(1). 82–86. 14 indexed citations

Mørk, Arne, Louise Witten, & Jørn Arnt. (2009). Effect of sertindole on extracellular dopamine, acetylcholine, and glutamate in the medial prefrontal cortex of conscious rats: a comparison with risperidone and exploration of mechanisms involved. Psychopharmacology. 206(1). 39–49. 38 indexed citations

10.

Hertel, P., Michael Didriksen, Bruno Pouzet, et al.. (2007). Lu 35-138 ((+)-(S)-3-{1-[2-(1-acetyl-2,3-dihydro-1H-indol-3-yl)ethyl]-3,6-dihydro-2H-pyridin-4-yl}-6-chloro-1H-indole), a dopamine D4 receptor antagonist and serotonin reuptake inhibitor: Characterisation of its in vitro profile and pre-clinical antipsychotic potential. European Journal of Pharmacology. 573(1-3). 148–160. 11 indexed citations

11.

Rodefer, Joshua S., et al.. (2007). Reversal of Subchronic PCP-Induced Deficits in Attentional Set Shifting in Rats by Sertindole and a 5-HT6 Receptor Antagonist: Comparison Among Antipsychotics. Neuropsychopharmacology. 33(11). 2657–2666. 109 indexed citations

12.

Sánchez, Connie, et al.. (1998). In vivo muscarinic cholinergic mediated effects of Lu 25-109, a M 1 agonist and M 2 /M 3 antagonist in vitro. Psychopharmacology. 137(3). 233–240. 6 indexed citations

13.

Arnt, Jørn, Torben Skarsfeldt, & John Hyttel. (1997). Differentiation of classical and novel antipsychotics using animal models. International Clinical Psychopharmacology. 12. S9–S18. 24 indexed citations

14.

Arnt, Jørn, et al.. (1996). The antiaggressive potency of (−)-penbutolol involves both 5-HT1A and 5-HT1B receptors and β-adrenoceptors. European Journal of Pharmacology. 297(1-2). 1–8. 16 indexed citations

15.

Bøgesø, Klaus P., Jørn Arnt, Kristen Frederiksen, et al.. (1995). Enhanced D1 Affinity in a Series of Piperazine Ring Substituted 1-Piperazino-3-Arylindans with Potential Atypical Antipsychotic Activity. Journal of Medicinal Chemistry. 38(22). 4380–4392. 38 indexed citations

16.

Arnt, Jørn, John Hyttel, & Connie Sánchez. (1992). Partial and full dopamine D1 receptor agonists in mice and rats: relation between behavioural effects and stimulation of adenylate cyclase activity in vitro. European Journal of Pharmacology. 213(2). 259–267. 124 indexed citations

17.

Arnt, Jørn, et al.. (1992). Discriminative stimulus properties of the muscarinic receptor agonists Lu 26-046 and O-Me-THPO in rats: evidence for involvement of different muscarinic receptor subtypes. European Journal of Pharmacology. 218(1). 159–169. 13 indexed citations

18.

Arnt, Jørn & John Hyttel. (1989). Facilitation of 8-OHDPAT-induced forepaw treading of rats by the 5-HT2 agonist DOI. European Journal of Pharmacology. 161(1). 45–51. 119 indexed citations

19.

Nowak, Gabriel, Jørn Arnt, & John Hyttel. (1988). EEDQ, a tool for ex vivo measurement of occupancy of D-1 and D-2 dopamine receptors. European Journal of Pharmacology. 153(2-3). 309–311. 26 indexed citations

20.

Arnt, Jørn & Jens Perregaard. (1987). Synergistic interaction between dopamine D-1 and D-2 receptor agonists: circling behaviour of rats with hemitransection. European Journal of Pharmacology. 143(1). 45–53. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact